Cargando…
Global genetic diversity of human apolipoproteins and effects on cardiovascular disease risk
Abnormal plasma apolipoprotein levels are consistently implicated in CVD risk. Although 30% to 60% of their interindividual variability is genetic, common genetic variants explain only 10% to 20% of these differences. Rare genetic variants may be major sources of the missing heritability, yet quanti...
Autores principales: | Zhou, Yitian, Mägi, Reedik, Milani, Lili, Lauschke, Volker M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society for Biochemistry and Molecular Biology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168301/ https://www.ncbi.nlm.nih.gov/pubmed/30076208 http://dx.doi.org/10.1194/jlr.P086710 |
Ejemplares similares
-
Association of serum HDL-cholesterol and apolipoprotein A1 levels with risk of severe SARS-CoV-2 infection
por: Hilser, James R., et al.
Publicado: (2021) -
Plasma apolipoprotein O level increased in the patients with acute
coronary syndrome
por: Yu, Bi-lian, et al.
Publicado: (2012) -
Effects of CETP inhibition with anacetrapib on metabolism of VLDL-TG and plasma apolipoproteins C-II, C-III, and E
por: Millar, John S., et al.
Publicado: (2017) -
Plasma proteoforms of apolipoproteins C-I and C-II are associated with plasma lipids in the Multi-Ethnic Study of Atherosclerosis
por: Koska, Juraj, et al.
Publicado: (2022) -
Adiposity significantly modifies genetic risk for dyslipidemia
por: Cole, Christopher B., et al.
Publicado: (2014)